Percutaneous treatment of congenital splenic cysts: drainage and sclerotherapy with polidocanol

A Yigit Goktay; Mustafa Secil; Mehmet Ali Ozcan; Oguz Dicle

doi:10.1007/s00270-004-0194-2

Percutaneous treatment of congenital splenic cysts: drainage and sclerotherapy with polidocanol

Cardiovasc Intervent Radiol. 2006 May-Jun;29(3):469-72. doi: 10.1007/s00270-004-0194-2.

Authors

A Yigit Goktay¹, Mustafa Secil, Mehmet Ali Ozcan, Oguz Dicle

Affiliation

¹ Department of Radiology, Dokuz Eylul University Hospital, Inciralti, Izmir, Turkey. [email protected]

PMID: 16184333
DOI: 10.1007/s00270-004-0194-2

Abstract

Congenital "true" splenic cysts are rare lesions. Therapeutic methods for the management of these lesions have been based on preserving splenic function due to the immunologic role of spleen. We report three different cases of congenital splenic cysts treated by percutaneous drainage and polidocanol sclerotherapy. This less invasive treatment appears to be safe and effective after 6 to 36 months of follow-up.

Publication types

Case Reports

MeSH terms

Adolescent
Adult
Contrast Media
Cysts / diagnostic imaging
Cysts / therapy*
Diagnosis, Differential
Female
Humans
Male
Polidocanol
Polyethylene Glycols / therapeutic use*
Sclerosing Solutions / therapeutic use*
Sclerotherapy / methods*
Splenic Diseases / diagnostic imaging
Splenic Diseases / therapy*
Tomography, X-Ray Computed
Ultrasonography

Substances

Contrast Media
Sclerosing Solutions
Polidocanol
Polyethylene Glycols